Sector News

Frutarom acquires full ownership of Enzymotec in $210m deal

October 30, 2017
Consumer Packaged Goods

Frutarom will acquire full ownership of Israeli flavour and ingredients company Enzymotec following a net investment of approximately $210 million.

Having previously held 19% of the company, the deal sees Frutarom purchase the remaining 81% at an average price of $11.9 per share, seeing Enzymotec become a full subsidiary.

Enzymotec, which was founded in 1998, develops, produces and markets nutritional ingredients and medical foods. Its total sales in the 12 months to June 2017 were $47 million, with its nutrition segment representing $36.5 million.

Over the past five years Enzymotec has invested around $30 million in R&D activity and clinical studies. It has approximately 100 registered patents and 90 patents pending at various stages of approval throughout the world.

Frutarom hopes the deal will see its products be of better value for its customers and that it will enhance its ability to produce ‘unique natural solutions combining taste and health’.

Ori Yehudai, president and CEO of Frutarom Group, believes the acquisition will boost the company’s activity in natural specialty fine ingredients based on innovation.

He said: “We particularly see Enzymotec’s nutrition segment as playing an important part in our future profitable growth strategy that will contribute to the expansion of the portfolio of comprehensive solutions for customers of both companies in the fields of pharmaceuticals, dietary supplements, designated foods for infants in the field of infant formula (where Frutarom has almost no activity currently) and elderly clinical nutrition in which Frutarom is active.

“We look forward to welcoming Enzymotec’s excellent and experienced management team and employees to the Frutarom family and we are convinced they will provide significant reinforcement to the ranks of our management, R&D, and sales and marketing, production and supply chain.”

Enzymotec chairman Steve Dubin added: “We are pleased that we have reached an amicable agreement with Frutarom in a manner that benefits our shareholders.

“We believe that our customers will also benefit from the merger through Frutarom’s global presence and our employees will have the opportunity to thrive under Frutarom’s leadership as one of the world’s top companies in its field.”

Enzymotec has 235 employees, mainly in Israel and the US. Its products will benefit from Frutarom’s global sales platform which includes over 100 marketing centres and around 1,000 salespeople who sell to over 30,000 customers.

The deal, which is Frutarom’s ninth acquisition of 2017 so far, is expected to close in the first quarter of 2018.

Source: FoodBev

comments closed

Related News

April 20, 2024

Tereos opens new innovation centre for EU customers

Consumer Packaged Goods

The facility is designed to foster innovation and deepen collaboration with customers, by offering a range of new services and solidifying its role as a central hub for customer support. Tereos’ team, supported by a network of 50 scientists, will ensure customers can innovate and meet the rising consumer demand for healthier and more sustainable products.

April 20, 2024

Glanbia to buy US flavour platform in $300m deal

Consumer Packaged Goods

Glanbia has agreed to acquire Flavor Producers from Aroma Holding for an initial consideration of $300 million. Flavor Producers is a US-based flavour platform, providing flavours and extracts to the F&B industries, with a focus on organic and natural ingredients.

April 20, 2024

Godiva names former Nike executive as president to boost sales

Consumer Packaged Goods

Lesnard, who previously worked at Nike, The North Face and Sephora, has a mission to “grow and sustain GODIVA’s position and expertise in the premium chocolate category, leveraging ongoing support from pladis to take GODIVA and its legendary chocolate to new heights.”

How can we help you?

We're easy to reach